 Roche will publish its Full Year Results of 2024 prior to the opening of the Swiss Stock Exchange on Thursday, 30 January 2025. 07:00 CET / 06:00 GMT / 01:00 AM EST / 10:00 PM PST (evening before) Release will be e-mailed and posted on the Roche IR website > click here Presentation slides will be posted on the Roche IR website > click here 14:00 – 16:00 CET / 13:00 – 15:00 GMT 08:00 – 10:00 AM EST / 05:00 - 07:00 AM PST The webinar will start with presentations by senior management, followed by a Q&A session. Presenters:
We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.* Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the webinar will be available via > ir.roche.com *privacy notice Best regards, | ||
| Bruno Eschli Head of Investor Relations | | |
| Roche Investor Relations | |
| Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
| Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com | |
| | |
| Investor Relations North America | |
| Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com | |
get the latest news and updates to your inbox.